CCL5 and glioblastoma: We detected high level US28-specific release of Ca++ in response to CCL5/RANTES or CX3CL1/Fractalkine in primary smooth muscle cells but not in the glioblastoma derived cells, although it is currently unclear why US28 would fail to induce this response in the glioblastoma cells.